Viatris

Viatris Inc.
Company type	Public
Traded as	Nasdaq: VTRS; S&P 500 component;
ISIN	US92556V1061
Industry	Pharmaceuticals; Healthcare;
Predecessors	Mylan; Upjohn;
Founded	November 16, 2020
Headquarters	Canonsburg, Pennsylvania, U.S.
Area served	Worldwide
Key people	Scott A. Smith (CEO); Sanjeev Narula (CFO); Rajiv Malik (President);
Products	Medicines; generic drugs; biosimilars; active pharmaceutical ingredients;
Revenue	US$16.26 billion (2022)
Net income	US$2.1 billion (2022)
Total assets	US$50.02 billion (2022)
Total equity	US$21.1 billion (2022)
Number of employees	c. 38,000 (2022)
Subsidiaries	Oyster Point Pharma; Famy Life Sciences;
Website	viatris.com
	Footnotes / references;

Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020.

The name of the corporation comes from the Latin words via, meaning path, and tris, which means three, referring to the path to three main objectives the corporation set: expanding access to medicines, meeting patient needs through innovation, and earning the trust of the healthcare community.

Viatris ranked 254th on the 2021 Fortune 500 rankings of the largest United States corporations based on its 2020 total revenue.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.